Skip to main content
SpringerLink
Log in

Does the Planning Target Volume Correlate with Toxicity for Head and Neck Cancer Patients Undergoing Radiation? A Prospective Observational Study

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Tolerance to radiation depends on the tumor volume; the greater the volume, the higher the toxicities. In this study, we aimed to study the impact of planning target volume (PTV) on toxicities in head and neck cancer (HNC) patients assigned to receive radiation with or without chemotherapy. Planning target volume (PTV) of 35 histologically proven non-nasopharyngeal head and neck cancer patients undergoing radiation with or without chemotherapy was recorded in cubic centimeters (cc). Their PTV high risk (PTVH) and PTV low risk (PTVL) were correlated with mucositis and dermatitis assessed weekly during treatment and at 2 weeks and 6 weeks post treatment. Thirty-five patients were treated with chemoradiation. Their mean PTVH was 278.08 cc (83–812 cc). The mean PTVL was 505.5 (44–1173 cc). Grade II and above mucositis was seen around fourth week and dermatitis and dysphagia by the end of fifth week which persisted till 2 weeks post follow-up in majority of patients. A cutoff of PTVH > 220 cc and PTVL > 550 cc correlated with grade 2 and above toxicities. Head and neck cancer patients with PTV 66 Gy > 220 cc need to be monitored closely during chemoradiation as they are likely to develop severe grades of toxicities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Poddar A, Aranha R, Royam MM, Gothandam KM, Nachimuthu R, Jayaraj R (2019) Incidence, prevalence, and mortality associated with head and neck cancer in India: protocol for a systematic review. Indian J Cancer 56(2):101

    Article  PubMed  Google Scholar 

  2. Kulkarni MR (2013) Head and neck cancer burden in India. Int J Head and Neck Surg 4(1):29–35

    Article  Google Scholar 

  3. Pignon JP, le Maître A, Maillard E, Bourhis J (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92(1):4–14

    Article  PubMed  Google Scholar 

  4. Common Terminology Criteria for Adverse Events (CTCAE) Version 5. Published: November 27. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute

  5. Carper E, Fleishman SB, McGuire M (2004) Symptom management and supportive care for head and neck cancer patients. In: Harrison LB, Sessions RB, Hong WK (eds) Head and neck cancer: a multidisciplinary approach. Philadelphia: Lippincott, Williams, and Wilkins

    Google Scholar 

  6. Lydiatt WM, Patel SG, O’Sullivan B, Brandwein MS, Ridge JA, Migliacci JC et al (2017) Head and neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin 67(2):122–37

    Article  PubMed  Google Scholar 

  7. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK et al (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66:253–62

    Article  PubMed  Google Scholar 

  8. Ahlawat P, Rawat S, Kakria A, Pal M, Chauhan D, Tandon S et al (2016) Tumour volumes: predictors of early treatment response in locally advanced head and neck cancers treated with definitive chemoradiation. Reports Pract Oncol Radiother 21(5):419–426

    Article  Google Scholar 

  9. Studer G, Lütolf UM, El-Bassiouni M, Rousson V, Glanzmann C (2007) Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT. Acta Oncol (Madr) 46(3):386–394

    Article  CAS  Google Scholar 

  10. Kurek R, Kalogera-Fountzila A, Muskalla K, Dafni U, Schnabel T, Kober B et al (2003) Usefulness of tumor volumetry as a prognostic factor of survival in head and neck cancer. Strahlentherapie Und Onkol 179(5):292–297

    Article  Google Scholar 

  11. Manur J, Vidyasagar N (2020) Correlation of planning target volume with mucositis for head-and-neck cancer patients undergoing chemoradiation. J Cancer Res Ther 16(3):565–568

    Article  CAS  PubMed  Google Scholar 

  12. Mallick I, Gupta SK, Ray R, Sinha T, Sinha S, Achari R et al (2013) Predictors of weight loss during conformal radiotherapy for head and neck cancers - how important are planning target volumes? Clin Oncol 25(9):557–563

    Article  CAS  Google Scholar 

  13. Blanco AI, Chao C (2006) Management of radiation-induced head and neck injury. Cancer Treat Res 128:23–41

    Article  PubMed  Google Scholar 

  14. Nathu RM, Mancuso AA, Zhu TC, Mendenhall WM (2000) The impact of primary tumor volume on local control for oropharyngeal squamous cell carcinoma treated with radiotherapy. Head Neck 22(1):1–5

    Article  CAS  PubMed  Google Scholar 

  15. Strongin A, Yovino S, Taylor R, Wolf J, Cullen K, Zimrin A et al (2012) Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy. Int J Radiat Oncol Biol Phys 82(5):1823–1830

    Article  PubMed  Google Scholar 

  16. Plataniotis GA, Theofanopoulou ME, Kalogera-Fountzila A, Haritanti A, Ciuleanou E, Ghilezan N et al (2004) Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma (non-nasopharyngeal) treated by radiotherapy alone or combined radiochemotherapy in a randomized trial. Int J Radiat Oncol Biol Phys 59(4):1018–1026

    Article  PubMed  Google Scholar 

  17. Nurkic S, Nurkic T, Morris CG, Amdur RJ, Mendenhall WM (2018) Preradiotherapy tumor volume in local control of squamous cell carcinoma of the supraglottic larynx. Am J Clin Oncol Cancer Clin Trials 41(11):1089–1093

    Article  Google Scholar 

  18. Koiwai K, Shikama N, Sasaki S, Shinoda A, Kadoya M (2009) Risk factors for severe dysphagia after concurrent chemoradiotherapy for head and neck cancers. Jpn J Clin Oncol 39(7):413–417

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Ramaiah Medical College, Bangalore, 560054, Karnataka, India

    Sneha Ujjayani & Manur Gururajachar Janaki

Authors
  1. Sneha Ujjayani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manur Gururajachar Janaki
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors have participated in (a) conception and design or analysis and interpretation of the data, (b) drafting the article or revising it critically for important intellectual content, and (c) approval of the final version.

Corresponding author

Correspondence to Sneha Ujjayani.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This manuscript has not been submitted to nor is under review at another journal or other publishing venue.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ujjayani, S., Janaki, M.G. Does the Planning Target Volume Correlate with Toxicity for Head and Neck Cancer Patients Undergoing Radiation? A Prospective Observational Study. Indian J Surg Oncol (2024). https://doi.org/10.1007/s13193-024-01905-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13193-024-01905-1

Keywords

Search

Navigation